SII vaccine for 3+ kids by mid-2022; Covavax trial shown excellent results [details]

SII CEO Adar Poonawalla announced the launch of Covavax, a covid vaccine for children above 3 years of age. A billion-dollar has been invested in the development of Covid-19 vaccines and the supply chain has outmatched the demand globally.

Related Keywords

India ,Novavax Covid ,Adar Poonawalla ,Confederation Of Indian Industries ,Serum Institute Of India ,Pune Based Serum Institute ,Indian Industries ,Zydus Healthcare ,Representational Image ,Vaccine ,Vaccine Trials ,Sii ,Covavax ,